Agenus Announces Upcoming AACR 2026 Presentation Evaluating Botensilimab Plus Balstilimab in First-Line MSS Metastatic Colorectal Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/4/2026

1. KRG
2. PRYMY
3. SPY
4. SKA-B
5. PBA
6. ALAR
7. CCH:LN
8. META
9. CCHGY
10. PRY:IM

Go back to Agenus Announces Upcoming AACR 2026 Presentation Evaluating Botensilimab Plus Balstilimab in First-Line MSS Metastatic Colorectal Cancer
AGENUS (NASDAQ: AGEN) Delayed: 3.49 +0.08 (2.35%)
Previous Close $3.41    52 Week High $7.49 
Open $3.40    52 Week Low $2.61 
Day High $3.52    P/E N/A 
Day Low $3.37    EPS $-1.10 
Volume 680,579